ELVN
Enliven Therapeutics Inc.
$19.92
+$0.96(+5.06%)
40
Overall
--
Value
40
Tech
--
Quality
Market Cap
$1.12B
Volume
423.26K
52W Range
$13.30 - $30.03
Target Price
$41.13
EPS Estimates Overview
| Current Quarter | $-0.43 | Next Quarter | $-0.47 |
| Current Year | $-1.95 | Next Year | $-2.19 |
| QoQ Growth | -9.3% | YoY Growth | -12.3% |
| 3Y EPS CAGR | N/A | Target Price | $41.13 |
| Consensus | Buy | Upside | +106.5% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ELVN | $19.92 | +5.1% | 423.26K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Enliven Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW